SARS-CoV-2(2019-nCoV), SARS-CoV
ELISA, Neutralization
Human
IgG1, kappa
S309
Middle East respiratory syndrome-related coronavirus (isolate UnitedKingdom/H123990006/2012) (MERS-CoV) (Betacoronavirus England 1)
ELISA, Neutralization
Human
IgG1, kappa
m336
Middle East respiratory syndrome-related coronavirus (isolate UnitedKingdom/H123990006/2012) (MERS-CoV) (Betacoronavirus England 1)
ELISA, Neutralization
Human
IgG1, kappa
D12
Middle East respiratory syndrome-related coronavirus (isolate United Kingdom/H123990006/2012) (MERS-CoV) (Betacoronavirus England 1)
Neutralization
Human
IgG1, kappa
S41
Human betacoronavirus 2c EMC/2012
ELISA, Neutralization
Human
IgG1, kappa
4C2
SARS-CoV-2
ELISA, Neutralization
Human
IgG1
PR961
SARS-CoV-2
ELISA, Neutralization
Human
IgG1, kappa
C102
SARS-CoV-2
ELISA, Neutralization
Human
IgG1, kappa
C144
SARS-CoV-2
ELISA, Neutralization
Human
IgG1, kappa
C105
SARS-CoV-2
Neutralization
Human
IgG1, kappa
5E1#